Equities analysts predict that Safeguard Scientifics, Inc (NYSE:SFE) will announce earnings of $1.61 per share for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Safeguard Scientifics’ earnings. Safeguard Scientifics posted earnings per share of ($0.91) in the same quarter last year, which indicates a positive year over year growth rate of 276.9%. The company is scheduled to announce its next quarterly earnings results on Thursday, October 25th.
On average, analysts expect that Safeguard Scientifics will report full-year earnings of ($0.79) per share for the current fiscal year. For the next fiscal year, analysts forecast that the company will post earnings of ($3.12) per share. Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts that cover Safeguard Scientifics.
Safeguard Scientifics (NYSE:SFE) last announced its quarterly earnings results on Thursday, July 26th. The asset manager reported ($1.21) EPS for the quarter, missing the Zacks’ consensus estimate of ($1.08) by ($0.13).
Shares of NYSE SFE traded up $0.05 during trading on Friday, hitting $10.20. The stock had a trading volume of 46,900 shares, compared to its average volume of 98,308. Safeguard Scientifics has a 12 month low of $9.85 and a 12 month high of $14.40. The company has a debt-to-equity ratio of 1.60, a current ratio of 5.03 and a quick ratio of 5.03. The firm has a market cap of $208.56 million, a price-to-earnings ratio of -2.35 and a beta of 1.28.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Renaissance Technologies LLC grew its stake in shares of Safeguard Scientifics by 68.1% in the 2nd quarter. Renaissance Technologies LLC now owns 270,437 shares of the asset manager’s stock worth $3,462,000 after acquiring an additional 109,556 shares in the last quarter. Prescott Group Capital Management L.L.C. bought a new stake in shares of Safeguard Scientifics in the 2nd quarter worth $1,406,000. Legal & General Group Plc grew its stake in shares of Safeguard Scientifics by 13.8% in the 2nd quarter. Legal & General Group Plc now owns 87,683 shares of the asset manager’s stock worth $1,122,000 after acquiring an additional 10,639 shares in the last quarter. Schwab Charles Investment Management Inc. grew its stake in shares of Safeguard Scientifics by 13.2% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 109,978 shares of the asset manager’s stock worth $1,408,000 after acquiring an additional 12,834 shares in the last quarter. Finally, SG Americas Securities LLC bought a new stake in shares of Safeguard Scientifics in the 2nd quarter worth $141,000. Hedge funds and other institutional investors own 72.64% of the company’s stock.
Safeguard Scientifics Company Profile
Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.
Recommended Story: Stock Symbol
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.